We are live on ! Find out more
NFA

Nationwide Fund Advisors Portfolio holdings

AUM $2.42B
1-Year Est. Return 17.68%
This Fund
S&P 500
This Quarter Est. Return
+5.79%
1 Year Est. Return
+17.68%
3 Year Est. Return
+28.25%
5 Year Est. Return
+4.07%
10 Year Est. Return
+82.68%
AUM
$23.9B
AUM Growth
+$802M
Cap. Flow
-$183M
Cap. Flow %
-0.77%
Top 10 Hldgs %
10.35%
Holding
3,340
New
74
Increased
975
Reduced
1,112
Closed
111

Top Buys

Rank Stock Value
1
CAG icon
Conagra Brands
CAG
+$29.6M
2
WM icon
Waste Management
WM
+$28.1M
3
AMZN icon
Amazon
AMZN
+$28.1M
4
JNJ icon
Johnson & Johnson
JNJ
+$24.7M
5
ABBV icon
AbbVie
ABBV
+$24M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$30.1M
2
EMC
EMC CORPORATION
EMC
+$28.3M
3
NKE icon
Nike
NKE
+$24.2M
4
RTN
Raytheon Company
RTN
+$24.1M
5
BMY icon
Bristol-Myers Squibb
BMY
+$22.4M

Sector Composition

Rank Sector Weight
1 Technology 15.97%
2 Healthcare 14.22%
3 Financials 13.72%
4 Industrials 11.98%
5 Consumer Discretionary 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRUP icon
2701
Trupanion
TRUP
$1.08B
$171K ﹤0.01%
10,107
TVRD
2702
Tvardi Therapeutics
TVRD
$19M
$171K ﹤0.01%
570
+9
+2% +$1.95K
INST
2703
DELISTED
Instructure, Inc.
INST
$171K ﹤0.01%
6,748
KODK icon
2704
Kodak
KODK
$874M
$170K ﹤0.01%
11,353
OXFD
2705
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$170K ﹤0.01%
13,511
ALTO icon
2706
Alto Ingredients
ALTO
$410M
$169K ﹤0.01%
24,455
+4,053
+20% +$26.1K
CLAR icon
2707
Clarus
CLAR
$129M
$167K ﹤0.01%
32,554
+3,114
+11% +$14.2K
COLL icon
2708
Collegium Pharmaceutical
COLL
$1.16B
$167K ﹤0.01%
8,665
CTO
2709
CTO Realty Growth
CTO
$819M
$167K ﹤0.01%
11,999
CMRX
2710
DELISTED
Chimerix, Inc.
CMRX
$167K ﹤0.01%
30,079
ALTA
2711
DELISTED
Altabancorp
ALTA
$167K ﹤0.01%
8,190
OSBC icon
2712
Old Second Bancorp
OSBC
$1.31B
$166K ﹤0.01%
19,928
DLTH icon
2713
Duluth Holdings
DLTH
$159M
$165K ﹤0.01%
6,213
NKSH icon
2714
National Bankshares
NKSH
$262M
$165K ﹤0.01%
4,494
STRP
2715
DELISTED
Straight Path Communications Inc.
STRP
$165K ﹤0.01%
6,439
APFH
2716
DELISTED
AdvancePierre Foods Holdings
APFH
$165K ﹤0.01%
+5,992
New +$151K
LMAT icon
2717
LeMaitre Vascular
LMAT
$2.42B
$164K ﹤0.01%
8,249
-1,044
-11% -$18.2K
LOCO icon
2718
El Pollo Loco
LOCO
$503M
$163K ﹤0.01%
12,985
ACBI
2719
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
$163K ﹤0.01%
10,898
BSTC
2720
DELISTED
BioSpecifics Technologies Corp.
BSTC
$163K ﹤0.01%
3,563
PRMW
2721
DELISTED
Primo Water Corporation
PRMW
$163K ﹤0.01%
13,442
ATLO icon
2722
AMES National
ATLO
$276M
$162K ﹤0.01%
5,855
BHB icon
2723
Bar Harbor Bankshares
BHB
$682M
$162K ﹤0.01%
6,617
NERV icon
2724
Minerva Neurosciences
NERV
$188M
$162K ﹤0.01%
1,430
+133
+10% +$12.9K
HEOP
2725
DELISTED
Heritage Oaks Bancorp
HEOP
$162K ﹤0.01%
19,795
+3,380
+21% +$27.6K

Similar funds

Nationwide Fund Advisors's Q3 2016 Portfolio in Review

As of Q3 2016, Nationwide Fund Advisors held 3,340 positions worth $23.9B, up 3.5% from $23.1B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Nationwide Fund Advisors's Q3 2016 filing shows 74 new, 975 increased, 1,112 reduced and 111 closed positions. Its largest new stake was GSK: 285,626 shares worth $15.4M. The largest sale was Broadcom, an estimated $30.1M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.

  • Nationwide Fund Advisors's largest Q3 2016 buy was GSK: 285,626 shares worth $15.4M.
  • Nationwide Fund Advisors added most to Conagra Brands in Q3 2016, an estimated $29.6M increase.
  • Nationwide Fund Advisors's biggest Q3 2016 reduction was Broadcom, cutting an estimated $30.1M.
  • Nationwide Fund Advisors fully exited EMC CORPORATION in Q3 2016, selling an estimated $28.3M.
  • Nationwide Fund Advisors's ten largest holdings make up 10% of its $23.9B portfolio in Q3 2016.
  • Nationwide Fund Advisors opened 74 new positions and closed 111 in Q3 2016.
  • Nationwide Fund Advisors's portfolio value rose 3.5% quarter-over-quarter to $23.9B.

Based on Nationwide Fund Advisors's 13F filing for Q3 2016, filed 20 Oct 2016.